Physician

Jeffrey Devin Redshaw, M.D.

According to 2025 Medicare claims, Jeffrey Redshaw, M.D. (NPI: 1134548597) practices urology in the Missoula, MT market, with the plurality of this provider's patient population coming from Missoula, MT. This provider's primary affiliated billing organization is FIVE VALLEYS UROLOGY (NPI: 1720067705; TIN: 651167362) and primary practice location at 59808-1582. Redshaw is affiliated with the Health Connect Partners, LLC (ACO ID: A2342), Caravan Collaborative Pathways (ACO ID: A4604), Caravan Health ACO 50 LLC (ACO ID: A5160), MountainStar Care Partners ACO (ACO ID: A5181), Collaborative ACO 30, LLC (ACO ID: A5483), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Redshaw's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 603 traditional Medicare patients, billed 8,549 HCPCS/CPT codes, and received $560,979 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 849 prescription claims across 275 beneficiaries totaling $728,562 in drug costs, led by Orgovyx (Relugolix). DME data shows 189 claims. Open Payments data shows 27 records totaling $958. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $96,650 to $560,979. Similarly, Part D prescription costs have risen steadily, from $1,696 to $728,562. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	166	1,317	$96,650
2020	433	6,390	$293,626
2021	455	6,759	$327,074
2022	495	9,708	$349,934
2023	514	8,350	$464,047
2024	603	8,549	$560,979

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	55	112	$1,696
2017	107	199	$13,107
2018	60	118	$924
2019	74	139	$2,851
2020	187	391	$27,198
2021	236	605	$115,036
2022	242	666	$77,209
2023	230	626	$228,962
2024	275	849	$728,562

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	40	$15,441
2021	N/R	68	$25,424
2022	14	174	$31,011
2023	11	150	$34,420
2024	40	189	$42,470

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	214	287	$97
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	161	196	$63
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	233	304	$12
51798	Ultrasound measurement of bladder capacity after voiding	113	136	$9
36415	Insertion of needle into vein for collection of blood sample	100	146	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Orgovyx	Relugolix	97	2,908	$243,664
Erleada	Apalutamide	13	390	$193,473
Xtandi	Enzalutamide	13	390	$186,746
Abiraterone Acetate	Abiraterone Acetate	51	1,530	$55,102
Myrbetriq	Mirabegron	20	1,488	$21,236

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4352	Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), each	N	N/R	44	$29,159
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	43	$8,814
A4385	Ostomy skin barrier, solid 4 x 4 or equivalent, extended wear, without built-in convexity, each	N	N/R	16	$3,269
A4357	Bedside drainage bag, day or night, with or without anti-reflux device, with or without tube, each	N	12	22	$432
A4338	Indwelling catheter; foley type, two-way latex with coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	17	22	$276

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	27	$958	Astellas Pharma US Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jeffrey Devin Redshaw, M.D.?

Tedicare shows public-source Medicare data for Jeffrey Devin Redshaw, M.D. (NPI 1134548597), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jeffrey Devin Redshaw, M.D. have ACO affiliation data?

Jeffrey Devin Redshaw, M.D. is shown with ACO affiliation data for Health Connect Partners, LLC (MSSP, ACO ID A2342), Caravan Collaborative Pathways (MSSP, ACO ID A4604), Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), MountainStar Care Partners ACO (MSSP, ACO ID A5181), Collaborative ACO 30, LLC (MSSP, ACO ID A5483), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Jeffrey Devin Redshaw, M.D.?

Jeffrey Devin Redshaw, M.D. is linked to FIVE VALLEYS UROLOGY (billing NPI 1720067705) in the available physician profile data.

Does Jeffrey Devin Redshaw, M.D. have Open Payments data?

Jeffrey Devin Redshaw, M.D. has 27 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.